Isotope Availability March 2020
A new batch of high-specific activity copper-67 will be ready to ship to customers in mid-April 2020. The deadline to place an order for the batch is April 10, 2020. The DOE IP has developed this production capability to increase the domestic supply of this isotope to the research community.
A new batch of strontium-89 will be available through the DOE IP in April 2020. The radioactive isotope is most commonly used in cancer therapy to relieve pain associated with cancer that has spread to the bone. Currently, the DOE IP is the only U.S. domestic supplier of strontium-89.
The DOE IP inventory of selenium-75 has been replenished and is available for purchase. The isotope is of interest in the science community for its use in biochemical and environmental research.
Our inventory of tungsten-188 has been replenished and is available for purchase now. Tungsten-188's decay product, rhenium-188, is a gamma and beta-emitting radionuclide of interest within the nuclear medicine community for a variety of therapeutic applications.
A new batch of accelerator-produced actinium-225 will be available through the DOE IP in June 2020. This alpha-emitting radionuclide and its decay product bismuth-213, from an actinium-225/bismuth-213 generator, have gained considerable interest within the medical community for their radioimmunotherapy applications.